A detailed history of Catalina Capital Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Catalina Capital Group, LLC holds 2,330 shares of AMGN stock, worth $745,972. This represents 0.25% of its overall portfolio holdings.

Number of Shares
2,330
Previous 2,117 10.06%
Holding current value
$745,972
Previous $661 Million 13.5%
% of portfolio
0.25%
Previous 0.25%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$309.38 - $337.38 $65,897 - $71,861
213 Added 10.06%
2,330 $751 Million
Q2 2024

Jul 24, 2024

BUY
$262.75 - $319.31 $30,741 - $37,359
117 Added 5.85%
2,117 $661 Million
Q1 2024

May 03, 2024

BUY
$268.87 - $324.56 $211,869 - $255,753
788 Added 65.02%
2,000 $569 Million
Q4 2023

Apr 30, 2024

BUY
$255.7 - $288.46 $309,908 - $349,613
1,212 New
1,212 $349 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Catalina Capital Group, LLC Portfolio

Follow Catalina Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalina Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalina Capital Group, LLC with notifications on news.